2014年発表論文

2016.12.20

2014年に当教室で発表した総説です。

題名（論文名）	著者（演者）	掲載雑誌
アンチアンドロゲン薬の新展開	溝上敦	ptostate journal 1: 193-197, 2014.
男性におけるHPVと性感染症	重原一慶、並木幹夫	日性感染症学会誌 25: 9-26, 2014.
最新の治療法　新規副腎性アンドロゲン合成酵素阻害薬	溝上敦	日本臨床 72: 2158-2163, 2014.
【ロボット支援下内視鏡的前立腺全摘出術を安全かつ有効に行うための創意・工夫】尿失禁防止を中心として	角野佳史	泌尿外科 27: 1445-1451, 2014.
高リスク前立腺癌に対する治療戦略の確立　TRIP試験（第2報）	小中弘之	泌尿外科 27: 1365-1368, 2014.
泌尿器科手術のすべて	北川育秀	泌尿器ケア2014（夏季増刊）: 223-232, 2014.
手術手技　女性泌尿器関連の手術	北川育秀、栗林正人、成本一隆、並木幹夫	臨床泌尿器 68: 303-306, 2014.
前立腺癌の診療ナビゲーション	溝上敦、中嶋憲一	臨床泌尿器 68: 76-81, 2014.
泌尿器疾患の診かた　陰嚢異常の取り扱い方	角野佳史	レジデントノート16: 2133-2139, 2014.

2014年に当教室で発表した和文原著です。

題名（論文名）	著者（演者）	掲載雑誌
当院男性外来を受診した性機能障害患者におけるphosphodiesterase 5阻害剤の効果と使用感の相違　高齢者と非高齢者の比較検討	重原一慶、門本卓、岩本大旭、宮城徹、中嶋孝夫、島村正喜	石川県立中央病院医学誌 36: 9-12, 2014.
テストステロン軟膏（グローミン）の6か月投与における前身効果に関する前向き試験	重原一慶、杉本和宏、島村正喜、宮城徹、中嶋孝夫、高栄哲、並木幹夫	日性機能会誌 29: 249-255, 2014.
骨盤臓器脱の外科的治療	成本一隆、竹山政美、並木幹夫	日本医師会雑誌 142: 2406, 2014.
泌尿器科からみたMen’s Health LUTSとテストステロン	重原一慶、並木幹夫	泌尿外科 27: 665-666, 2014.
限局性および局所進行前立腺癌に対する外照射併用高線量率組織内照射の治療成績	牧野友幸、溝上敦、並木幹夫	泌尿外科 27: 1353-1357, 2014.

2014年に当教室で発表した英文原著です。

題名（論文名）	著者（演者）	掲載雑誌
Age-specific reference range of prostate-specific antigen and prostate cancer detection in population-based screening cohort in Japan: verification of Japanese Urological Association Guideline for prostate cancer.	Kitagawa Y, Izumi K, Sawada K, Mizokami A, Nakashima K, Koshida K, Nakashima T, Miyazaki K, Namiki M.	Int J Urol. 2014; 21(11):1120-5.
Androgen receptor, ccl2, and epithelial-mesenchymal transition: A dangerous affair in the tumor microenvironment.	Lin WJ, Izumi K.	Oncoimmunology. 2014;3:e27871.
Androgen receptor roles in the development of benign prostate hyperplasia.	Izumi K, Mizokami A, Lin WJ, Lai KP, Chang C.	Am J Pathol. 2013; 182(6):1942-9.
Clinical characteristics and prostate-specific antigen kinetics of prostate cancer detected in repeat annual population screening in Japan.	Kitagawa Y, Sawada K, Mizokami A, Nakashima K, Koshida K, Nakashima T, Miyazaki K, Takeda Y, Namiki M	Int J Urol. 2014; 21(5):461-5
Comparison of testosterone fractions between Framingham Heart Study participants and Japanese participants.	Taya M, Koh E, Izumi K, Iijima M, Maeda Y, Matsushita T, Iwamoto T, Namiki M.	Int J Urol. 2014; 21(7):689-95.
New molecular diagnostic kit to assess Y-chromosome deletions in the Japanese population.	Iijima M, Koh E, Izumi K, Taya M, Maeda Y, Kyono K, Yoshida A, Namiki M.	Int J Urol. 2014; 21(9):910-6
Cumulative probability of prostate cancer detection in biopsy according to free/total PSA ratio in men with total PSA levels of 2.1-10.0 ng/ml at population screening.	Kitagawa Y, Ueno S, Izumi K, Kadono Y, Konaka H, Mizokami A, Namiki M.	J Cancer Res Clin Oncol. 2014 Jan;140(1):53-9.
Cumulative probability of prostate cancer detection using the international prostate symptom score in a prostate-specific antigen-based population screening program in Japan.	Kitagawa Y, Urata S, Narimoto K, Nakagawa T, Izumi K, Kadono Y, Konaka H, Mizokami A, Namiki M.	Asian Pac J Cancer Prev. 2014;15(17):7079-83.
Decreasing trend in prostate cancer with high serum prostate-specific antigen levels detected at first prostate-specific antigen-based population screening in Japan.	Kitagawa Y, Machioka K, Yaegashi H, Nakashima K, Ofude M, Izumi K, Ueno S, Kadono Y, Konaka H, Mizokami A, Namiki M.	Asian J Androl. 2014;16(6):833-7.
Differential diagnosis between bacterial infection and neoplastic fever in patients with advanced urological cancer: the role of procalcitonin.	Yaegashi H, Izumi K, Kitagawa Y, Kadono Y, Konaka H, Mizokami A, Namiki M.	Int J Urol. 2014; 21(1):104-6
Lower Urinary Tract Symptoms are Associated with Erectile Function and Psychological Symptoms in Men with Late-Onset Hypogonadism Syndrome.	Shigehara K, Sugimoto K, Konaka H, Maeda Y, Kitagawa Y, Mizokami A, Koh E, Namiki M.	Low Urin Tract Symptoms. 2014; 6(3):151-6.
Cytological evaluation using liquid-based cytology in the male urogenital tract infected with human papillomavirus.	Shigehara K, Sasagawa T, Kawaguchi S, Nakashima K, Nakashima T, Shimamura M, Furubayashi K, Namiki M.	Diagn Cytopathol. 2014; 42(6):491-7.
Effects of bethanechol chloride and distigmine bromide on postvoiding residual volume in patients with underactive bladder.	Izumi K, Maolake A, Maeda Y, Shigehara K, Namiki M.	Minerva Urol Nefrol. 2014;66(4):241-7.
Effects of dutasteride on lower urinary tract symptoms and general health in men with benign prostatic hypertroplasia and hypogonadism: a prospective study.	Shigehara K, Koh E, Sakamoto J, Yaegashi H, Izumi K, Ueno S, Kitagawa Y, Maeda Y, Kadono Y, Konaka H, Mizokami A, Nakashima T, Namiki M.	Aging Male. 2014;17(1):51-6.
Prospective longitudinal comparative study of health-related quality of life and treatment satisfaction in patients treated with hormone therapy, radical retropubic prostatectomy, and high or low dose rate brachytherapy for prostate cancer.	Miwa S, Mizokami A, Konaka H, Ueno S, Kitagawa Y, Koh E, Namiki M.	Prostate Int. 2013;1(3):117-24.
Human papillomavirus infection and pathogenesis in urothelial cells: a mini-review.	Shigehara K, Sasagawa T, Namiki M.	J Infect Chemother. 2014; 20(12):741-7.
Prevalence of human papillomavirus infection in the oropharynx and urine among sexually active men: a comparative study of infection by papillomavirus and other organisms, including Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma spp., and Ureaplasma spp.	Nakashima K, Shigehara K, Kawaguchi S, Wakatsuki A, Kobori Y, Nakashima K, Ishii Y, Shimamura M, Sasagawa T, Kitagawa Y, Mizokami A, Namiki M.	BMC Infect Dis. 2014;14:43.
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer.	Izumi K, Li L, Chang C.	Clin Investig (Lond). 2014; 4(10):935-950.
Editorial comment to “Predictors of benign histology in clinical T1a renal cell carcinoma tumors undergoing partial nephrectomy”.	Izumi K.	Int J Urol. 2014; 21(1):103
Editorial comment to “Recent status of the treatment of stress urinary incontinence”.	Kitagawa Y.	Int J Urol. 2014; 21(1):32
Inflammatory myofibroblastic tumor of the urinary bladder with benign pelvic lymph node enlargement: a case report.	Machioka K, Kitagawa Y, Izumi K, Kitamura S, Ikeda H, Namiki M.	Case Rep Oncol. 2014; 7(2):571-5.
Intrapelvic fat makes robot-assisted radical prostatectomy difficult.	Kadono Y, Ueno S, Makino T, Ofude M, Izumi K, Gabata T, Namiki M.	Anticancer Res. 2014; 34(10):5523-8.
Metastatic Urothelial Carcinoma of the Prepuce and Glans Penis: Suspected Implantation of Non-Muscle-Invasive Bladder Cancer via Urine.	Makino T, Kitagawa Y, Namiki M.	Case Rep Oncol. 2014; 7(2):509-12
Nadir prostate-specific antigen (PSA) level and time to PSA nadir following primary androgen deprivation therapy as independent prognostic factors in a Japanese large-scale prospective cohort study (J-CaP).	Kitagawa Y, Ueno S, Izumi K, Mizokami A, Hinotsu S, Akaza H, Namiki M.	J Cancer Res Clin Oncol. 2014; 140(4):673-9.
New molecular diagnostic kit to assess Y-chromosome deletions in the Japanese population.	Iijima M, Koh E, Izumi K, Taya M, Maeda Y, Kyono K, Yoshida A, Namiki M.	Int J Urol. 2014; 21(9):910-6.
Optimal treatment for castration-resistant prostate cancer.	Izumi K, Namiki M.	Asian J Androl. 2014; 16(3):498.
Outcomes and predictive factors of prostate cancer patients with extremely high prostate-specific antigen level.	Izumi K, Lin WJ, Miyamoto H, Huang CK, Maolake A, Kitagawa Y, Kadono Y, Konaka H, Mizokami A, Namiki M.	J Cancer Res Clin Oncol. 2014; 140(8):1413-9.
Predictive factor and antihypertensive usage of tyrosine kinase inhibitor-induced hypertension in kidney cancer patients.	Izumi K, Itai S, Takahashi Y, Maolake A, Namiki M.	Oncol Lett. 2014; 8(1):305-308.
SOD3 acts as a tumor suppressor in PC-3 prostate cancer cells via hydrogen peroxide accumulation.	Kim J, Mizokami A, Shin M, Izumi K, Konaka H, Kadono Y, Kitagawa Y, Keller ET, Zhang J, Namiki M.	Anticancer Res. 2014; 34(6):2821-31.
Urodynamic evaluation before and immediately after robot-assisted radical prostatectomy.	Kadono Y, Ueno S, Yaegashi H, Ofude M, Izumi K, Maeda Y, Mizokami A, Miwa S, Miyagi T, Namiki M.	Urology. 2014; 84(1):106-11.

一覧に戻る